跳至主要内容
临床试验/NCT03255551
NCT03255551已完成不适用

Blood Pressure Lowering Effects of Amosartan Regarding Proviso in Patients With Hypertension: Prospective, Multicenter, Observational Study

Seoul National University Bundang Hospital0 个研究点目标入组 50 人开始时间: 2014年1月1日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
50
主要终点
Patients with essential hypertension evaluated the mean blood pressure after taking amosartan.

研究概览

简要总结

Blood Pressure Lowering Effects of Amosartan Regarding Proviso in Patients with Hypertension

详细描述

After taking Amozatan (AMS, amlodipine / rozanthin combination) in patients with essential hypertension, the percentage of patients who reached the mean systolic target blood pressure was evaluated

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with essential hypertension whose blood pressure is not adequately controlled by amlodipine or rosartan monotherapy
  • In patients with stage 2 hypertension (SBP 160-179 mmHg), patients requiring a combination therapy to reach the target blood pressure
  • Patients who were changed to amosartan while using other hypertensive agents

排除标准

  • Patients with hypersensitivity to dihydropyridine derivatives of amosartan
  • Women who are pregnant or who may be pregnant and breastfeeding
  • Patients with severe hepatic dysfunction
  • Patients with severe aortic stenosis
  • Patients at risk of shock
  • Patients participating in other clinical studies

结局指标

主要结局

Patients with essential hypertension evaluated the mean blood pressure after taking amosartan.

时间窗: 6 month

Blood Pressure Lowering Effects of Amosartan Regarding Proviso in Patients with Hypertension

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dong-Ju Choi

Seoul National University Bundang Hospital

Seoul National University Bundang Hospital

相似试验